A Leading Contract Research Organization
StatPlus, Inc., a leading contract research organization was founded in 1998. StatPlus distinguishes itself from its competitors in the services of high quality, speed, and excellence.
The StatPlus staff of experienced clinical scientists, statisticians and data managers collaborate as a team to deliver top-notch services. In addition, a number of distinguished medical consultants are on staff providing technical guidance and supervision to help pharmaceutical companies, biotech, medical device, medical researchers and government agencies into a deeper understanding of scientific advances.
At StatPlus, our mission is to provide clients with high quality services, which include biopharmaceutical applications in the areas of clinical research all within their budget and timeframe. We are committed to accomplish this mission through integrity, innovation and data-driven.
We offer comprehensive services in the areas of Drug Development, Medical Device, and Clinical Research. Our services cover the entire spectrum of the development process.
StatPlus Milestone
1998 : Company formed and provided full services for Clinical Research
1999 : Received 1st Taiwan DoH GCP Inspection
2000 : Provided services for US clients in statistical analysis
2005 : Attended US FDA site inspection in Taiwan
2007 : Submitted US FDA IND Study
2009 : Conducted H1N1 Flu Vaccines Studies in Taiwan
2011 : Formed Asia CRO Alliance including Japan, Korea, Hong Kong, Vietnam, Thailand, Malaysia, Singapore, Philippines and Taiwan
2017 : DM&ST Services for China Study
2020 : Conduct Covid-19 Vaccine Phase I Study in Taiwan
2021 : Covid-19 Vaccine Phase II Study